ARK Investment Management Holds 12.9% Stake in Intellia Therapeutics
Ticker: NTLA · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 1652130
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, amendment, biotech, gene-editing
TL;DR
**ARK still owns a huge chunk of Intellia, signaling strong conviction.**
AI Summary
ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, revealing a significant stake in Intellia Therapeutics, Inc. As of December 31, 2023, ARK beneficially owned 11,412,449 shares of Intellia's common stock, representing 12.9% of the company. This filing indicates ARK's continued conviction in Intellia, a gene-editing company, and signals to investors that a major institutional player sees long-term value, potentially influencing stock price and investor sentiment.
Why It Matters
This filing shows that a prominent institutional investor, ARK Investment Management, maintains a substantial position in Intellia Therapeutics, which can be seen as a vote of confidence and may attract other investors.
Risk Assessment
Risk Level: low — This filing indicates a stable, significant institutional holding, which generally reduces volatility and provides a level of investor confidence.
Analyst Insight
A smart investor would view this as a positive signal, suggesting that a well-known institutional investor sees long-term potential in Intellia Therapeutics. This might prompt further research into Intellia's fundamentals and ARK's investment thesis for the company.
Key Numbers
- 11,412,449 — Aggregate Shares Beneficially Owned (This is the total number of Intellia Therapeutics shares ARK Investment Management LLC owned as of December 31, 2023.)
- 12.9% — Percentage of Class (This represents the percentage of Intellia Therapeutics' common stock owned by ARK Investment Management LLC, indicating a significant stake.)
- December 31, 2023 — Date of Event (This is the date as of which the ownership stake was calculated for this filing.)
- January 29, 2024 — Filing Date (This is the date the SC 13G/A amendment was filed with the SEC.)
Key Players & Entities
- ARK Investment Management LLC (company) — the reporting person and institutional investor
- Intellia Therapeutics, Inc. (company) — the subject company whose stock is being reported
- Delaware (place) — place of organization for ARK Investment Management LLC
- Cathie Wood (person) — CEO of ARK Investment Management LLC (implied by ARK's identity)
Forward-Looking Statements
- ARK Investment Management will likely maintain a significant stake in Intellia Therapeutics for the foreseeable future. (ARK Investment Management LLC) — high confidence, target: 2025-12-31
- Intellia Therapeutics' stock price may experience increased stability due to this large institutional holding. (Intellia Therapeutics, Inc.) — medium confidence, target: 2024-07-31
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment (Amendment No. 6) to a Schedule 13G, indicating a change in the beneficial ownership of Intellia Therapeutics, Inc. common stock by ARK Investment Management LLC, as required by Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the reporting person in this filing and what is their organizational structure?
The reporting person is ARK Investment Management LLC, an organization incorporated in Delaware, United States. Their business address is 200 Central Avenue, St. Petersburg, FL 33701.
How many shares of Intellia Therapeutics, Inc. did ARK Investment Management LLC beneficially own as of the event date?
As of December 31, 2023, ARK Investment Management LLC beneficially owned an aggregate of 11,412,449 shares of Intellia Therapeutics, Inc. common stock.
What percentage of Intellia Therapeutics, Inc.'s common stock does ARK Investment Management LLC own?
ARK Investment Management LLC beneficially owns 12.9% of the common stock of Intellia Therapeutics, Inc., based on the aggregate amount beneficially owned as of December 31, 2023.
What are the sole and shared voting and dispositive powers held by ARK Investment Management LLC over these shares?
ARK Investment Management LLC holds sole voting power over 10,761,522 shares and shared voting power over 331,673 shares. They hold sole dispositive power over 11,412,449 shares and shared dispositive power over 0 shares.
Filing Stats: 940 words · 4 min read · ~3 pages · Grade level 7.8 · Accepted 2024-01-29 16:00:59
Filing Documents
- tm244117d16_sc13g.htm (SC 13G/A) — 42KB
- 0001104659-24-007686.txt ( ) — 44KB
(a) Name of issuer
Item 1(a) Name of issuer: Intellia Therapeutics, Inc.
(b) Address of issuer's principal executive offices
Item 1(b) Address of issuer's principal executive offices: 40 Erie Street, Suite 130, Cambridge, MA 02139
(a) Name of person filing
Item 2(a) Name of person filing: ARK Investment Management LLC
(b) Address or principal business office or, if none,
Item 2(b) Address or principal business office or, if none, residence: ARK Investment Management LLC 200 Central Avenue St. Petersburg, FL 33701
(c) Citizenship
Item 2(c) Citizenship: Delaware, United States
(d) Title of class of securities
Item 2(d) Title of class of securities: Common stock
(e) CUSIP No
Item 2(e) CUSIP No.: 45826J105
If this statement is filed pursuant to §§ 240.13d-1(b) or
Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ CUSIP No. 45826J105 13G Page 4 of 5 Pages
Ownership
Item 4. Ownership (a) Amount beneficially owned: 11,412,449 (b) Percent of class: 12.74% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 10,761,522 (ii) Shared power to vote or to direct the vote: 331,673 (iii) Sole power to dispose or to direct the disposition of: 11,412,449 (iv) Shared power to dispose or to direct the disposition of: 0
Ownership of 5 Percent or Less of a Class
Item 5. Ownership of 5 Percent or Less of a Class. Not applicable.
Ownership of More than 5 Percent on Behalf of Another Person
Item 6. Ownership of More than 5 Percent on Behalf of Another Person. To the knowledge of the Reporting Person, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, a number of the shares which represents more than five percent of the number of outstanding class of the shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group. Not applicable.
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 45826J105 13G Page 5 of 5 Pages
Certifications
Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. The reporting persons agree that this statement is filed on behalf of each of them. Dated: January 29, 2024 ARK Investment Management LLC By: /s/ Kellen Carter Name: Kellen Carter Title: Chief Compliance Officer